BiotechTube
Home/Pipeline/Cancer Stem Cell Research

Cancer Stem Cell Research

Oncology

ResearchActive

Key Facts

Indication
Oncology
Phase
Research
Status
Active
Company
Avesthagen

About Avesthagen

Avesthagen leverages population genetics and systems biology through The Avestagenome Project® to develop predictive diagnostics and personalized healthcare solutions.

View full company profile

Therapeutic Areas

OncologyInfectious Disease

Other Oncology Drugs

DrugCompanyPhase
Bi-XDC with PROTACsCoherent BiopharmaIND-enabling
Bi-XDC with RPTCoherent BiopharmaEarly-stage
mRNA Anticancer VaccineSunshine BiopharmaPreclinical Research
Biosimilar BevacizumabOrganon (2)Phase 3
Biosimilar PembrolizumabOrganon (2)Phase 3
BCL-2 Inhibitor ProgramVincerx PharmaPreclinical
Not specified in provided content3SbioVarious
Preclinical ProjectsZion PharmaPreclinical
Attenukine Oncology CandidateTevaPhase 1
XEMA Tumor Marker ELISA KitXEMA GroupCommercial
KRAS inhibitorRisen Pharma TechPreclinical/Phase 1
KEAP1 Activator ProgramVividion TherapeuticsPhase 1